• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

CNS Pharmaceuticals, Inc. - Common Stock (NQ:CNSP)

5.380 +0.140 (+2.67%)
Streaming Delayed Price Updated: 2:58 PM EDT, Aug 7, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about CNS Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
23 24 Next >
News headline image
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
February 14, 2025
 
Via Benzinga
News headline image
Why Airbnb Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket ↗
February 14, 2025
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
February 11, 2025
 
Via Benzinga
BioMedNewsBreaks — CNS Pharmaceuticals Inc. (NASDAQ: CNSP) CEO to Present at BIO CEO & Investor Conference
February 10, 2025
Via Investor Brand Network
News headline image
CNS Pharmaceuticals to Present at the BIO CEO & Investor Conference
February 10, 2025
Via ACCESS Newswire
News headline image
CNS Pharmaceuticals to Host Virtual Analyst & Investor Day on December 11, 2024
December 05, 2024
Via ACCESSWIRE
News headline image
CNS Pharmaceuticals Reports Third Quarter 2024 Financial Results
November 15, 2024
Via ACCESSWIRE
Study Reveals Insights into How Needed Treatments Can Bypass the Blood-Brain Barrier
January 31, 2025
Via Investor Brand Network
Chinese Research Team Suggests Common Drug for Blood Pressure Could Treat Invasive Brain Tumor
January 10, 2025
Via Investor Brand Network
News headline image
12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
January 06, 2025
 
Via Benzinga
Research Shows Brain Tumors Grow by Hijacking Circadian Clocks
December 17, 2024
Via Investor Brand Network
BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) to Host Virtual Analyst & Investor Day on December 11
December 05, 2024
Via Investor Brand Network
New Graphene Chip Could Revolutionize Brain Cancer Treatment
November 08, 2024
Via Investor Brand Network
News headline image
CNS Pharmaceuticals Announces Virtual Investor KOL Connect Segment
November 04, 2024
Via ACCESSWIRE
AI Model Promises New Way to Detect Brain Malignancies
December 02, 2024
Via Investor Brand Network
Topics Artificial Intelligence Death
BioMedNewsBreaks — CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Presents Progress in Pivotal Study of Berubicin for Glioblastoma Treatment
November 25, 2024
Via Investor Brand Network
News headline image
CNS Pharmaceuticals Presents Update from Ongoing Potentially Pivotal Study of Berubicin Compared with Lomustine in Adult Patients with Recurrent GBM (WHO Grade IV) After Failure of Standard First Line Therapy
November 25, 2024
Via ACCESSWIRE
BioMedNewsBreaks — CNS Pharmaceuticals Inc. (NASDAQ: CNSP) to Present Berubicin Trial Update at Society for Neuro-Oncology Annual Meeting
November 18, 2024
Via Investor Brand Network
News headline image
CNS Pharmaceuticals Announces Abstract Accepted for Poster Presentation at the 29th Annual Meeting of the Society for Neuro-Oncology (SNO 2024)
November 18, 2024
Via ACCESSWIRE
BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Advances Glioblastoma Treatment with Berubicin Amid Strong Financial Position
November 15, 2024
Via Investor Brand Network
BioMedNewsBreaks — CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Highlights Berubicin’s Potential in Glioblastoma Treatment During KOL Connect Event
November 04, 2024
Via Investor Brand Network
BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Granted Nasdaq Extension for Compliance
November 01, 2024
Via Investor Brand Network
News headline image
CNS Pharmaceuticals Granted Exception by Nasdaq to Regain Compliance with Minimum Bid Price Requirement
November 01, 2024
Via ACCESSWIRE
Stocks Under Ten Cents to Watch in October 2024 CNSP, QLGN, AKTS, CBDW, RJDG
October 25, 2024
Via AB Newswire
BioMedNewsBreaks — CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Secures $3 Million in Registered Direct Offering
October 24, 2024
Via Investor Brand Network
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
October 24, 2024
 
Via Benzinga
News headline image
Why Tesla Shares Are Trading Higher By Around 11%; Here Are 20 Stocks Moving Premarket ↗
October 24, 2024
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's After-Market Session ↗
October 23, 2024
 
Via Benzinga
News headline image
Nasdaq Down 2%; US Crude Stocks Increase ↗
October 23, 2024
 
Via Benzinga
News headline image
Gold Moves Lower; AT&T Earnings Top Views ↗
October 23, 2024
 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
23 24 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap